ABVC BioPharma, Inc. (ABVC) vs aTyr Pharma, Inc. (ATYR)
ABVC BioPharma, Inc. and aTyr Pharma, Inc. are both Biotechnology companies. ABVC BioPharma, Inc. and aTyr Pharma, Inc. are of similar size ($34.0M and $31.4M). ABVC BioPharma, Inc. grew revenue faster over the last twelve months: 5,035.4% against 6.78%. Across the 15 metrics below, ABVC BioPharma, Inc. leads on 10 and aTyr Pharma, Inc. on 5.
Valuation
Profitability
| Metric | ABVC | ATYR | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.97% | 1.72% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (65.32%) | (98.67%) | (57.72%) |
| Return on assets | (39.88%) | (70.97%) | (49.22%) |
| Return on invested capital | (33.45%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack